Neurocrine Clinical Site

Orlando, Florida 32806

1 studies enrolling now · 9 studies all time

What they study most

Anhedonia, Cerebral Palsy, Dyskinesia, Major Depressive Disorder, Tardive Dyskinesia, Tardive Dyskinesia (TD), Tourette Syndrome

Studies at this site

• A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy — Completed
• Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD — Completed
• Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome — Stopped early
• Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome — Completed
• Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome — Completed
• Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia — Completed
• Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents — Status unconfirmed